Product logins

Find logins to all Clarivate products below.


Biosurgical Agents | Market Insights | US | 2023

The COVID-19 pandemic had a negative impact on the US biosurgical agent market. However, recovery of the deferred procedures and procedure volume growth will drive modest growth in the market over the forecast period. Moreover, the market will be driven by rising awareness of the clinical benefits of biosurgical agents in surgical procedures and product approvals for expanded indications.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for biosurgical agents in the US from 2019 through 2031.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Biosurgical Agents – Market Insights – Latin America (Supplemental)
The biosurgical agent market in Latin America will observe modest growth through 2033, primarily driven by the increasing number of procedures utilizing biosurgical agents, combined with favorable…
Report
Biosurgical Agents – Market Insights – Europe (Supplemental)
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by the growing number of procedures in which in biosurgical agents are used,…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth over the forecast period, driven by the rising volume of surgical procedures and heightened awareness of the…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…